アフターアワーズ： 28.51

Immunovant Inc (IMVT)

Immunovant Inc (IMVT) 最新ニュース

Immunovant Inc (IMVT)

Immunovant Inc (IMVT) 最新ニュース

(IMVT) Investment Analysis - Stock Traders Daily

Immunovant Inc (IMVT) is looking forward to a strong quarter - SETE News

Immunovant (NASDAQ:IMVT) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Blue Owl Capital Holdings LP Has $2.11 Million Stock Position in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Armistice Capital LLC Has $89.68 Million Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Fred Alger Management LLC Trims Stake in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Stocks of Immunovant Inc (IMVT) are poised to climb above their peers - SETE News

Immunovant, Inc. (NASDAQ:IMVT) is Armistice Capital LLC's 6th Largest Position - MarketBeat

Insider’s View: Deciphering Immunovant Inc (IMVT)’s Financial Health Through Ratios - The Dwinnex

Immunovant (NASDAQ:IMVT) Trading 2.7% Higher - MarketBeat

Immunovant (NASDAQ:IMVT) Trading Up 2.7% - Defense World

Oppenheimer initates Immunovant Inc (IMVT) stock to an Outperform - Knox Daily

A closer look at Immunovant Inc (IMVT)’s stock price trends - US Post News

Goldman Sachs sustains price target, buy rating on Immunovant shares By Investing.com - Investing.com Canada

Profund Advisors LLC Sells 18,864 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Profund Advisors LLC Sells 18,864 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Farallon Capital Management LLC Takes $317,000 Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Logos Global Management LP Sells 1,200,000 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Renaissance Technologies LLC Acquires 48,400 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Seven Eight Capital LP Has $279,000 Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Renaissance Technologies LLC Acquires 48,400 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Ankyra Announces Appointment of Dr. Julia Butchko and Ms. Tara Withington to the Board of Directors - StockTitan

Rubric Capital Management LP Purchases Shares of 58,624 Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Rubric Capital Management LP Invests $1.55 Million in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Rhumbline Advisers Has $2.21 Million Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by E Fund Management Co. Ltd. - Defense World

Trading (IMVT) With Integrated Risk Controls - Stock Traders Daily

Immunovant Inc (IMVT) did well last session? - US Post News

ImmunityBio, Inc. (NASDAQ:IBRX) Shares Purchased by Private Advisor Group LLC - Defense World

Roivant Deals Again, Sending Dermavant to Organon in Sale Worth Up to $1.2B - BioSpace

Quest Partners LLC Grows Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Recent Insider Activity Could Benefit Immunovant Inc (IMVT) - Knox Daily

IBRX Stock on the Rise: A Promising Investment - The InvestChronicle

WINTON GROUP Ltd Buys Shares of 20,675 Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

IVV And The S&P 500: How Bad Could It Get? (NYSEARCA:IVV) - Seeking Alpha

Headlands Technologies LLC Buys New Stake in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Immunic (NASDAQ:IMUX) Raised to Strong-Buy at EF Hutton Acquisition Co. I - MarketBeat

A new trading data show Immunovant Inc (IMVT) is showing positive returns. - SETE News

Balance Sheet Dive: Immunovant Inc (IMVT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Immunovant, Inc. (NASDAQ:IMVT) Stake Lessened by Los Angeles Capital Management LLC - Defense World

Victory Capital Management Inc. Boosts Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Victory Capital Management Inc. Cuts Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

TD Asset Management Inc Sells 32,242 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by TD Asset Management Inc - Defense World

First Turn Management LLC Buys 182,535 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

FY2026 EPS Estimates for Immunovant, Inc. (NASDAQ:IMVT) Decreased by Analyst - Defense World

Immunovant, Inc. to Post FY2026 Earnings of ($2.82) Per Share, Leerink Partnrs Forecasts (NASDAQ:IMVT) - MarketBeat

Bank of New York Mellon Corp Has $6.61 Million Holdings in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Immunovant, Inc. (NASDAQ:IMVT) Shares Acquired by Bank of New York Mellon Corp - Defense World

What the Options Market Tells Us About Immunovant - Benzinga

A stock that deserves closer examination: Immunovant Inc (IMVT) - US Post News

Financial Metrics Exploration: Understanding Immunovant Inc (IMVT) Through Ratios - The Dwinnex

Immunovant’s (IMVT) Buy Rating Reaffirmed at HC Wainwright - Defense World

IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab - MSN

Roivant reveals Phase 1b results for new pulmonary treatment - Investing.com

Immunovant (NASDAQ:IMVT) Given Buy Rating at HC Wainwright - MarketBeat

Roivant reveals Phase 1b results for new pulmonary treatment - Investing.com India

Immunovant Inc (IMVT) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Immunovant (NASDAQ:IMVT) Given “Overweight” Rating at Cantor Fitzgerald - Defense World

Immunovant (NASDAQ:IMVT) Shares Down 3.6% - MarketBeat

Immunovant, Inc. (NASDAQ:IMVT) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Immunovant, Inc. (NASDAQ:IMVT) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Immunovant Sees Unusually High Options Volume (NASDAQ:IMVT) - Defense World

Immunovant stock falls 8% amid Graves' disease program update (NASDAQ:IMVT) - Seeking Alpha

Immunovant’s Confidence In Graves’ Disease Builds - Scrip

Immunovant (NASDAQ:IMVT) Earns "Overweight" Rating from Cantor Fitzgerald - MarketBeat

IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab - Benzinga

Immunovant reports promising batoclimab trial results for Graves' Disease - Investing.com

What's Going In With Vivek Ramaswamy-Founded Roivant Sciences Stock On Monday? - Benzinga

Immunovant Sees Unusually High Options Volume (NASDAQ:IMVT) - MarketBeat

This trade activity should not be overlooked: Immunovant Inc (IMVT) - SETE News

Top 2 Health Care Stocks That May Collapse This Quarter - Benzinga

Immunovant touts positive Phase II batoclimab data as IMVT-1402 also progresses - Pharmaceutical Technology

IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab - Yahoo Finance

Immunovant Advances Groundbreaking Therapy in Graves’ Disease Trials - TipRanks

IMVTに似た銘柄